Literature DB >> 20423333

Challenges for and current status of research into positive modulators of AMPA receptors.

Simon E Ward1, Benjamin D Bax, Mark Harries.   

Abstract

AMPA receptors consist of a family of hetero-oligomeric (tetrameric) receptors arising from four genes, each of which encodes a distinct receptor subunit (GluA1-4). Recombinant homo-tetrameric AMPA receptors, comprising four identical subunits, are functionally active and have been used in in vitro assays. However, the many different subunit permutations make possible the functional and anatomical diversity of AMPA receptors throughout the CNS. Furthermore, AMPA receptor subunit stoichiometry influences the biophysical and functional properties of the receptor. A number of chemically diverse positive modulators of AMPA receptor have been identified which potentiate AMPA receptor-mediated activity in vitro as well as improving cognitive performance in rodents and non-human primates with several being taken further in the clinic. This review article summarizes the current status in the research on positive allosteric modulation of AMPA receptors and outlines the challenges involved in identifying a chemically distinct series of AMPA receptor positive modulators, addressing the challenges created by the heterogeneity of the AMPA receptor populations and the development of structure-activity relationships driven by homomeric, recombinant systems on high-throughput platforms. We also review the role of X-ray crystallography in the selection and prioritization of targets for lead optimization for AMPA receptor positive modulators.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20423333      PMCID: PMC2874841          DOI: 10.1111/j.1476-5381.2010.00726.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  66 in total

1.  Light and electron immunocytochemical localization of AMPA-selective glutamate receptors in the rat brain.

Authors:  R S Petralia; R J Wenthold
Journal:  J Comp Neurol       Date:  1992-04-15       Impact factor: 3.215

2.  Evidence that a positive modulator of AMPA-type glutamate receptors improves delayed recall in aged humans.

Authors:  G Lynch; R Granger; J Ambros-Ingerson; C M Davis; M Kessler; R Schehr
Journal:  Exp Neurol       Date:  1997-05       Impact factor: 5.330

3.  Effects of pharmacologically facilitating glutamatergic transmission in the trisynaptic intrahippocampal circuit.

Authors:  J Sirvio; J Larson; C N Quach; G A Rogers; G Lynch
Journal:  Neuroscience       Date:  1996-10       Impact factor: 3.590

Review 4.  Cloned glutamate receptors.

Authors:  M Hollmann; S Heinemann
Journal:  Annu Rev Neurosci       Date:  1994       Impact factor: 12.449

5.  Topology profile for a glutamate receptor: three transmembrane domains and a channel-lining reentrant membrane loop.

Authors:  J A Bennett; R Dingledine
Journal:  Neuron       Date:  1995-02       Impact factor: 17.173

6.  Biarylpropylsulfonamides as novel, potent potentiators of 2-amino-3- (5-methyl-3-hydroxyisoxazol-4-yl)- propanoic acid (AMPA) receptors.

Authors:  P L Ornstein; D M Zimmerman; M B Arnold; T J Bleisch; B Cantrell; R Simon; H Zarrinmayeh; S R Baker; M Gates; J P Tizzano; D Bleakman; A Mandelzys; K R Jarvie; K Ho; M Deverill; R K Kamboj
Journal:  J Med Chem       Date:  2000-11-16       Impact factor: 7.446

7.  Facilitation of glutamate receptors enhances memory.

Authors:  U Staubli; G Rogers; G Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

8.  7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S-dioxide (IDRA 21), a congener of aniracetam, potently abates pharmacologically induced cognitive impairments in patas monkeys.

Authors:  D M Thompson; A Guidotti; M DiBella; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

9.  Effects of a centrally active benzoylpyrrolidine drug on AMPA receptor kinetics.

Authors:  A Arai; M Kessler; J Ambros-Ingerson; A Quan; E Yigiter; G Rogers; G Lynch
Journal:  Neuroscience       Date:  1996-11       Impact factor: 3.590

10.  7-Chloro-3-methyl-3-4-dihydro-2H-1,2,4 benzothiadiazine S,S-dioxide (IDRA 21): a benzothiadiazine derivative that enhances cognition by attenuating DL-alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid (AMPA) receptor desensitization.

Authors:  I Zivkovic; D M Thompson; M Bertolino; D Uzunov; M DiBella; E Costa; A Guidotti
Journal:  J Pharmacol Exp Ther       Date:  1995-01       Impact factor: 4.030

View more
  22 in total

Review 1.  Synaptic neurotransmitter-gated receptors.

Authors:  Trevor G Smart; Pierre Paoletti
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-03-01       Impact factor: 10.005

2.  Pharmacological characterisation of MDI-222, a novel AMPA receptor positive allosteric modulator with an improved safety profile.

Authors:  Simon E Ward; Mark H Harries; Laura Aldegheri; Andrea M Bradford; Elisa Ballini; Lee Dawson; Laurent Lacroix; Joanne Pardoe; Kathryn Starr; Annette Weil; Kerry Waters; John R Atack; Marie Woolley
Journal:  J Psychopharmacol       Date:  2019-11-26       Impact factor: 4.153

3.  Functional analysis of a novel positive allosteric modulator of AMPA receptors derived from a structure-based drug design strategy.

Authors:  Jonathan E Harms; Morris Benveniste; John K F Maclean; Kathryn M Partin; Craig Jamieson
Journal:  Neuropharmacology       Date:  2012-06-23       Impact factor: 5.250

Review 4.  Structure and mechanism of glutamate receptor ion channel assembly, activation and modulation.

Authors:  Mark L Mayer
Journal:  Curr Opin Neurobiol       Date:  2011-02-23       Impact factor: 6.627

Review 5.  Functional insights from glutamate receptor ion channel structures.

Authors:  Janesh Kumar; Mark L Mayer
Journal:  Annu Rev Physiol       Date:  2012-09-04       Impact factor: 19.318

6.  Dynamics and allosteric potential of the AMPA receptor N-terminal domain.

Authors:  Madhav Sukumaran; Maxim Rossmann; Indira Shrivastava; Anindita Dutta; Ivet Bahar; Ingo H Greger
Journal:  EMBO J       Date:  2011-02-11       Impact factor: 11.598

7.  Subunit-selective allosteric inhibition of glycine binding to NMDA receptors.

Authors:  Kasper B Hansen; Kevin K Ogden; Stephen F Traynelis
Journal:  J Neurosci       Date:  2012-05-02       Impact factor: 6.167

8.  Structural and functional analysis of two new positive allosteric modulators of GluA2 desensitization and deactivation.

Authors:  David E Timm; Morris Benveniste; Autumn M Weeks; Eric S Nisenbaum; Kathryn M Partin
Journal:  Mol Pharmacol       Date:  2011-05-04       Impact factor: 4.436

9.  A combined bioinformatics and chemoinformatics approach for developing asymmetric bivalent AMPA receptor positive allosteric modulators as neuroprotective agents.

Authors:  Haijun Chen; Cheng Z Wang; Chunyong Ding; Christopher Wild; Bryan Copits; Geoffrey T Swanson; Kenneth M Johnson; Jia Zhou
Journal:  ChemMedChem       Date:  2012-12-20       Impact factor: 3.466

10.  Functional insight into development of positive allosteric modulators of AMPA receptors.

Authors:  Autumn M Weeks; Jonathan E Harms; Kathryn M Partin; Morris Benveniste
Journal:  Neuropharmacology       Date:  2014-05-27       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.